GeneReach Biotechnology (4171.TWO) Action Cours

GeneReach Biotechnology Corp, listed on the Taiwan Stock Exchange under ticker 4171.TWO with ISIN TW0004171004, is a health care company headquartered in Taichung, Taiwan. The company has 84 employees and completed its initial public offering on November 19, 2012. GeneReach focuses on developing, manufacturing, and marketing products related to applied nucleic acid detection technology. Its primary operations are conducted within Taiwan. The company offers a range of products including shrimp virus testing agents, on-site detection systems for fish and shrimp, mini centrifugal machines, and pet disease testing agents, alongside other testing equipment. GeneReach's business model centers on providing diagnostic solutions for aquaculture and veterinary applications. The company's website is https://www.genereach.com/, where further information about its products and services can be found. As a health care sector entity, GeneReach operates within the broader health care industry, contributing to diagnostic technology development and application in specific market segments. The company's product portfolio reflects a specialized focus on detection technologies for animal health and aquaculture, distinguishing it within the health care industry. Its operations are confined to the Taiwan market, with no indication of international expansion or additional regional operations provided in the available information.